Market Opens

Alan Green, Vice President, Head of ETFs, Dynamic Funds (“Company”), and his team joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to close the market and celebrate the launch of their three new ETFs: Dynamic Credit Opportunities Fund (TSX: DXCO), Dynamic Global Fixed Income Fund (TSX: DXBG), and Dynamic Short Term Credit PLUS Fund (TSX: DXCP). Dynamic Funds is proud to offer differentiated Active ETF solutions that aim to uncover opportunities beyond the benchmark through Legitimately Active Management®. Dynamic Funds is a division of 1832 Asset Management L.P., which offers a range of wealth management solutions, including mutual funds, actively managed ETFs, liquid alternative mutual funds and investment solutions for private clients, institutional clients and managed asset programs. The Company began by challenging the status quo in investment management, and it continues to do so today.

Patrick Searle, Vice President, Council of Canadian Innovators (“CCI” or the “Organization”) and his team, joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the 10th Cohort of CCI’s Innovation Governance Program (“iGP”). iGP has empowered over 1,000 graduates since 2021, providing the governance expertise and strategic insights needed to drive Canada’s fastest-growing firms in the global innovation economy. Together with partners like The TMX Group, iGP is shaping a future of resilient, globally competitive Canadian companies. Presented by the Council of Canadian Innovators (CCI), iGP is an award-winning, three-course specialization that equips current and prospective corporate directors with the tools to lead in the intangible economy. Each six-week level is offered virtually every Winter, Spring, and Fall. Participants engage in weekly discussions with board members and governance experts, exploring critical areas such as intellectual property and data governance, cybersecurity, finance, and risk management. Applications for the Winter 2025 iGP session (February–March) close on January 6. For more information, visit www.innovationgovernance.ca or attend an information session on November 28 or December 10. Learn more at igp.canadianinnovators.org/information-sessions.

Linda Williams, Managing Partner, Clients, Markets & Growth, EY Canada (“EY”), and Rachel Rodrigues, Partner and EY Entrepreneur Of The Year National Program Director, along with program winners, alumni, judges, program sponsors and firm executives, joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to close the market and celebrate the 30 years of Canada's EY Entrepreneur Of The Year program. Since 1994, EY has recognized more than 3300 finalists and 1450 award winners. The program highlights innovative entrepreneurs who excel in balancing passion, determination, character, and skill to create businesses that tackle complex challenges and contribute to shaping the future with confidence. Together with the EY Entrepreneurs Access Network and EY Entrepreneurial Winning Women, EY’s trio of entrepreneurship programs support business growth and scaling while fostering an inclusive ecosystem for all.

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (“Zero Candida” or the “Company”), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company’s new listing on the TSX Venture Exchange. Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis (“VVC”), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.